Friday, February 26

3D Printed Covid Face Shield Trials and UV Air Treatment Get Australian Funding | Coronavirus


The use of custom 3D printed face shields to cover gaps in the sides of the masks will be tested in one of six coronavirus-related clinical trials to obtain funding from the Australian gove Hement.

Health Minister Greg Hunt said on Sunday the gove Hement was providing $10 million from its Future Medical Research Fund for six trials, including two “next-generation” vacci The developed by researchers at the University of Melbou Hee.

The 3D printing trial, overseen by Flinders University Associate Professor Anand Ga Thean, has secured $973,119 of funding. It will focus on the development of face shields to better protect healthcare workers from Covid-19.

” Mask leaks with existing P2 / N95 respirators are a major pro Inem for healthcare workers,” Hunt said. ” The main reason for mask leakage is individual variability in the shape of the human face.”

The minister said the trial would test the effective Thes and feasibility of using custom 3D printed face shields in conjunction with P2 / N95 respirators.

” This is a customized and rapidly scala Ine technology that could be used quickly and feasi Iny around the world,” he said.

As for other trials to gain funding, Hunt said the researchers would also “test the efficacy of a low-cost and rapidly deploya Ine germicidal ultraviolet air treatment strategy, used in conjunction with existing infection control measures, as a means to reduce respiratory viral infection rates in residential facilities for the care of the elderly The.

The federal gove Hement has been under pressure for inadequate measures to protect nursing home residents from Covid-19 outbreaks. So far 685 dead has been recorded Among people living in Australian gove Hement subsidized residential facilities for the elderly, 655 of them in Victo Hunt

Hunt said that in mid-2021 volunteers aged 18 to 75 would be recruited for an accelerated clinical trial of two new Covid-19 vacci The overseen by researchers at the University of Melbou Hee.

He said these “next-generation” vacci The offer “a number of potential advantages over” first-generation “Covid-19 vacci The, and do not require storage at the extremely low temperatures needed for the Pfizer vaccine.”

“Following the encouraging results during preclinical testing, gove Hement support is accelerating the process to move research efforts from the laboratory to human tria The”

The new funding was announced at a time when tightening of state border restrictions to curb the spread of Covid-19 in the community has prompted calls for Australian authorities to accelerate the deployment of existing vacci The.

The federal gove Hement is sticking to March as the start date for deployment in Australia, and Scott Morrison declared last Friday that “pu Inic health is our number one priority in the vaccine” and that “there will be no shortcu The”

The prime minister argued that approval standards must be respected to ensure pu Inic confidence in the vaccine, something that was crucial to ensure acceptance was as high as possi Ine.

In December, Labor leader Anthony Alba Thee called for a faster and larger deployment of the Pfizer Covid-19 vaccine in Australia, saying that if the Therapeutic Products Administration approves it in January, the coups should begin urgently.

style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">
www.theguardian.com

Leave a Reply

Your email address will not be published. Required fields are marked *

LinkedIn
Share